Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone

The capacity to direct migration ('homing') of blood-borne cells to a predetermined anatomic compartment is vital to stem cell–based tissue engineering and other adoptive cellular therapies. Although multipotent mesenchymal stromal cells (MSCs, also termed 'mesenchymal stem cells') hold the potential for curing generalized skeletal diseases, their clinical effectiveness is constrained by the poor osteotropism of infused MSCs (refs. 1–3). Cellular recruitment to bone occurs within specialized marrow vessels that constitutively express vascular E-selectin, a lectin that recognizes sialofucosylated determinants on its various ligands. We show here that human MSCs do not express E-selectin ligands, but express a CD44 glycoform bearing α-2,3-sialyl modifications. Using an α-1,3-fucosyltransferase preparation and enzymatic conditions specifically designed for treating live cells, we converted the native CD44 glycoform on MSCs into hematopoietic cell E-selectin/L-selectin ligand (HCELL), which conferred potent E-selectin binding without effects on cell viability or multipotency. Real-time intravital microscopy in immunocompromised (NOD/SCID) mice showed that intravenously infused HCELL+ MSCs infiltrated marrow within hours of infusion, with ensuing rare foci of endosteally localized cells and human osteoid generation. These findings establish that the HCELL glycoform of CD44 confers tropism to bone and unveil a readily translatable roadmap for programming cellular trafficking by chemical engineering of glycans on a distinct membrane glycoprotein.

[1]  C. E. van der Schoot,et al.  Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. , 1996, The American journal of pathology.

[2]  R. Sackstein,et al.  A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity. , 2000, Blood.

[3]  P. Frenette,et al.  Enforced fucosylation of neonatal CD34+ cells generates selectin ligands that enhance the initial interactions with microvessels but not homing to bone marrow. , 2005, Blood.

[4]  M. Polly.  CD62 and endothelial cell-liukocyte adhesion molicule 1 (ELAM-1) recognize the same carbohy drate ligand, sialyl-Lewis , 1991 .

[5]  S. Hakomori,et al.  CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  T. Springer,et al.  The integrin VLA-4 supports tethering and rolling in flow on VCAM-1 , 1995, The Journal of cell biology.

[7]  Chi‐Huey Wong,et al.  Mechanism and specificity of human α-1,3-fucosyltransferase V , 1996 .

[8]  S. Rafii,et al.  Cd44 Is a Major E-Selectin Ligand on Human Hematopoietic Progenitor Cells , 2001, The Journal of cell biology.

[9]  R. Sackstein.  The lymphocyte homing receptors: gatekeepers of the multistep paradigm , 2005, Current opinion in hematology.

[10]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[11]  L. Muul,et al.  Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K Ann McKibbon,et al.  Current status and future prospects. , 2008, Health information and libraries journal.

[13]  C. Figdor,et al.  The Small GTPase Rap1 Is Required for Mn2+- and Antibody-induced LFA-1- and VLA-4-mediated Cell Adhesion* , 2002, The Journal of Biological Chemistry.

[14]  R. Fuhlbrigge,et al.  A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Eric R. Prossnitz,et al.  Real Time Analysis of the Affinity Regulation of α4-Integrin , 2001, The Journal of Biological Chemistry.

[16]  Xunbin Wei,et al.  In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment , 2005, Nature.

[17]  M. Auffredou,et al.  Manganese induces apoptosis of human B cells: caspase-dependent cell death blocked by Bcl-2 , 1999, Cell Death and Differentiation.

[18]  Paul J Campagnola,et al.  Second harmonic generation imaging of endogenous structural proteins. , 2003, Methods.

[19]  Catherine M. Verfaillie,et al.  Pluripotency of mesenchymal stem cells derived from adult marrow , 2007, Nature.

[20]  J. Lévesque,et al.  Dual control by divalent cations and mitogenic cytokines of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity expressed by human hemopoietic cells. , 1998, Cell adhesion and communication.

[21]  J. Ingwall,et al.  Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts , 2003, Nature Medicine.

[22]  F. Taylor,et al.  Divergent inducible expression of P-selectin and E-selectin in mice and primates. , 1999, Blood.

[23]  L. Xia,et al.  Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow. , 2004, Blood.

[24]  D. Kaplan,et al.  Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. , 2005, Tissue engineering.

[25]  R. Cummings,et al.  Discordant expression of selectin ligands and sialyl Lewis x-related epitopes on murine myeloid cells. , 2002, Blood.

[26]  J. Mocco,et al.  HuEP5C7 as a Humanized Monoclonal Anti-E/P-Selectin Neurovascular Protective Strategy in a Blinded Placebo-Controlled Trial of Nonhuman Primate Stroke , 2002, Circulation research.

[27]  Zhang Xue-guang,et al.  Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro. , 2004, Experimental hematology.

[28]  A. Caplan,et al.  The Dynamic in vivo Distribution of Bone Marrow-Derived Mesenchymal Stem Cells after Infusion , 2001, Cells Tissues Organs.

[29]  Carl Wood,et al.  Current Status and Future Prospects , 1984 .

[30]  M. Pittenger,et al.  Mesenchymal stem cells and their potential as cardiac therapeutics. , 2004, Circulation research.

[31]  U. V. von Andrian,et al.  Total body irradiation causes profound changes in endothelial traffic molecules for hematopoietic progenitor cell recruitment to bone marrow. , 2002, Blood.

[32]  J. Lian,et al.  Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. , 1975, Proceedings of the National Academy of Sciences of the United States of America.